Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Combining Cyclosporine A with low-dose corticosteroids effectively treats severe alopecia areata.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Tjalma Syndrome is a rare condition in people with lupus, causing fluid buildup and high CA-125 levels, but not due to tumors.

A woman in Sri Lanka was diagnosed with lupus after presenting with protein loss from the gut and other symptoms.

A scalp biopsy revealed systemic amyloidosis in a woman who initially seemed to have a common hair loss condition.

Skin issues like hair loss, rash, and sensitivity to sunlight are key signs of lupus activity.

Most patients with systemic lupus erythematosus in Malwa, India, show skin symptoms like photosensitivity and rashes.

Young women with lupus often have oral ulcers.

Women with lupus experienced non-scarring hair loss with fewer hair follicles, and the test for lupus in hair was not helpful.

Finasteride treatment lowers urine androgen and prostaglandin levels, making them potential markers for effectiveness.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Fibromyalgia slightly more common in SLE patients but doesn't affect SLE activity assessments.

Pregnancy can cause skin pigmentation, stretch marks, and changes in hair, nails, and sweat glands, with most resolving after birth.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Acne is a chronic disease linked to various systemic conditions and has significant psychological and social effects.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Most pregnant women experience skin darkening and hair changes, with these effects usually going away after giving birth.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

Older adults commonly experience wrinkles, itchy skin, psoriasis, fungal infections, skin growths, grey hair, hair loss, and nail ridging, but no skin cancer was found in this group.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Some skin medications can harm male fertility, but they don't seem to cause birth defects from father's exposure.